
Dr. Ross C Donehower M.D.
Oncologist | Medical Oncology
10755 Falls Rd Lutherville Timonium MD, 21093About
Dr. Ross Donehower is an oncologist practicing in Lutherville Timonium, MD. Dr. Donehower specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Donehower manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Absorption, metabolism, and excretion of 14C-temozolomide following oral
- Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
- Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors.
- A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumors.
- Role of oral chemotherapy in colorectal cancer.
- Phase II study of 4-ipomeanol, a naturally occurring alkylating furan, in patients with advanced hepatocellular carcinoma.
- Tumor targeting by conjugation of DHA to paclitaxel.
- A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies.
- Bioavailability of penclomedine and systemic exposure to 4-O-demethylpenclomedine in patients receiving oral and intravenous penclomedine.
- A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.
- Evolving therapies: farnesyltransferase inhibitors.
- Metabolism and urinary excretion of a new quinoline anticancer drug, TAS-103, in humans.
- Disposition of docosahexaenoic acid-paclitaxel, a novel taxane, in blood: in vitro and clinical pharmacokinetic studies.
- Is HIF-1 alpha a valid therapeutic target?
- A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly.
Dr. Ross C Donehower M.D.'s Practice location
Practice At 10755 Falls Rd
10755 Falls Rd -Lutherville Timonium, MD 21093Get Direction
Dr. Ross C Donehower M.D.'s reviews
Write ReviewRecommended Articles
- Eva Longoria On Her Sister with Special Needs Having Breast Cancer
Eva Longoria has recently opened up on a subject that she hasn't discussed too much in the past. She has a special needs sister who was diagnosed with breast cancer. Eva is now using her celebrity platform to raise awareness and support for her beloved sister. Liza is not only Eva Longoria's...
- What are the Signs and Symptoms of Pancreatic Cancer?
Do you want to know the signs and symptoms of pancreatic cancer? Symptoms of this disease typically depend on the location of the cancer. Please note that those who have pancreatic cancer typically see their symptoms manifest only after the cancer grows beyond the pancreas itself. This makes it a...
- Use Breast Shields to Reduce Radiation Damage During CT Scans
Using breast shields will reduce radiation damage to the breast tissue in men and women who undergo CT scans of the chest, according to a new study. This small metallic piece does not affect the diagnosis, according to researchers. “This may reduce the radiation to the breast tissues by about...
- Nausea and Vomiting as Symptoms of Colon Cancer
The majority of people with colon cancer do not experience any symptoms during the early stages of the disease. However, there are early signs of colon cancer that we need to be aware of.Colon cancer usually starts to occur with the development of non-cancerous (benign) polyps. These polyps develop...
- What Is Cachexia?
Cachexia is a wasting syndrome, which is a process that causes fat tissues and muscle to waste away. This disorder causes involuntary weight loss, which often affects people with late-stage chronic diseases, such as cancer, renal disease, HIV or AIDS, and congestive heart failure.People with...
- Risk-Reduction Mastectomy for those with Ovarian Cancer
A risk-reducing mastectomy is a type of surgical procedure that involves the removal of a woman’s breasts when there is an increased risk of developing breast cancer, yet there is no sign of breast cancer. Any woman who has had breast cancer is considered at high-risk of developing breast cancer...
Nearby Providers
- Dr. Johann Brandes MD, PHD1650 Orleans Street Baltimore MD 21231
- Dr. Kit Lu M.D.4940 Eastern Ave Baltimore MD 21224
- Dr. Julie Brahmer M.D.401 North Broadway Baltimore Maryland 21231
- Dr. Ivan Marques Borrello M.D.1650 ORLEANS ST BALTIMORE MD 21263
- Dr. Mark Levis M.D.1800 Orleans St Baltimore MD 21287
- Dr. Evan Jacob Lipson MD1650 Orleans St Baltimore MD 21287